Search
for

    Sort by

    Research 91–120 of 1000+

    1. Management of Dermatologic Toxicities Journal of the National Comprehensive Cancer Network · 2015 · 12 citations
    2. Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer Journal of thoracic oncology · 2006 · 12 citations
    3. Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital Anais Brasileiros de Dermatologia · 2021 · 7 citations
    4. A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor Annals of oncology · 2012 · 4 citations
    5. Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases Chemical Immunology · 2012 · 4 citations
    6. Dermatologic Adverse Events from Cancer Treatments Springer eBooks · 2018 · 2 citations
    7. Management of Toxicities of Targeted Therapies Elsevier eBooks · 2018 · 2 citations
    8. Cutaneous Side Effects of Chemotherapy and Radiotherapy 2016 · 2 citations
    9. Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 2 citations
    10. Continuous MEK inhibition by AZD6244 (ARRY-142886) results in exhaustion of the cutaneous keratinocytic stem cell pool and resembles senescence driven skin aging Journal of Clinical Oncology · 2008 · 2 citations
    11. Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review Clinical Cosmetic and Investigational Dermatology · 2025 · 1 citations
    12. When bugs and drugs conspire: driving acneiform skin toxicity 2020 · 1 citations
    13. Adverse Hair Reactions to New Targeted Therapies for Cancer Actas Dermo-Sifiliográficas · 2019 · 1 citations
    14. Pathogenesis and management of TRPV3-related Olmsted syndrome Frontiers in Genetics · 2024
    15. ISID1338 - Epidermal growth factor receptor protects from immune privilege collapse and scarring hair follicle destruction 2023
    16. 1338 Epidermal growth factor receptor protects from immune privilege collapse and scarring hair follicle destruction 2023
    17. PRIDE syndrome with lumbosacral hypertrichosis Dermatology Review · 2022
    18. A Story About Hair Oncology Times · 2018
    19. Proceedings of the Heinz Maurer-Symposium “Review and Preview in Science for Healthy Skin” June 28th 2014, Jakobsberg, Boppard, Germany Aktuelle Dermatologie · 2014
    20. The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship Dermatology Online Journal · 2009
    21. Treatment of acne with intermittent isotretinoin, cohort study 1998
    22. PRIDE syndrome associated with panitumumab treatment – case report and literature review Przegląd Dermatologiczny · 2023 · 1 citations
    23. Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity EMBO Molecular Medicine · 2024
    24. 645 MIG6 is MEK-regulated and affects EGF-induced migration in mutant NRAS melanoma Journal of Investigative Dermatology · 2016
    25. Trichomegaly of the eyelashes following treatment with cetuximab Annals of oncology · 2005 · 78 citations
    26. Cetuximab Induced Hidrocystomas: A Case Report SKIN The Journal of Cutaneous Medicine · 2020
    27. The relevance of collagen XVII expression in epidermal differentiation and proliferation Journal of dermatological science · 2016
    28. An unusual terminal hair growth on the nose tip associated with gefitinib therapy British Journal of Dermatology · 2007 · 4 citations
    29. Prevention of erlotinib-induced folliculitis with doxycycline Dermatologic Therapy · 2016 · 3 citations
    30. Molecular Docking Studies and ADME Prediction of Novel Isatin Analogs with Potent Anti-EGFR Activity Medicinal chemistry · 2014 · 15 citations